← Leaderboards
Koichi Takahashi
University Of Tx Md Anderson Can Ctr
$2,384,988
Attributed
$3,777,435
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $949.8K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,777,435 · 3
By mechanism
R01$2,088,671 · 1
P01$1,688,764 · 2
Top collaborators
- Kapil N. Bhalla4 shared
- Courtney Dinardo4 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Lauren Averett Byers$9,117,683
- Kapil N. Bhalla$16,921,043
- Courtney Dinardo$2,316,391
- Eduardo Vilar Sanchez$16,310,319
- Scott Kopetz$13,199,822
Others in their field
Other Emerging Leaders on “Mutation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$85,874,322
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,421,310
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$38,744,543
- Lynn Briscoe · Leidos Biomedical Research, Inc.$38,032,945
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- James Dale Berry · Brigham And Women'S Hospital$19,118,191
Research focus
MutationHematopoiesisMutantChemotherapyData SetComplexEpigenetic ProcessMolecularResponseTranscriptome SequencingMalignant - DescriptorArchitectureAdultBioinformatics ResourceBioinformaticsBiogenesisAnimalsClinical ManagementChip-SeqAcute Myeloid Leukemia CellCellular Indexing Of Transcriptomes And Epitopes By SequencingChromiumClinically RelevantAnalog
Grant awards (8)
Core A: Single Cell Profiling and Bioinformatics Core$452,288
P01 · FY2025 · CA · contact PI
Novel combination therapy for AML expressing mutant RUNX1$507,478
R01 · FY2024 · CA
Core A: Single Cell Profiling and Bioinformatics Core$438,166
P01 · FY2024 · CA · contact PI
Novel combination therapy for AML expressing mutant RUNX1$523,503
R01 · FY2023 · CA
Core A: Single Cell Profiling and Bioinformatics Core$372,000
P01 · FY2023 · CA · contact PI
Novel combination therapy for AML expressing mutant RUNX1$523,503
R01 · FY2022 · CA
Core A: Single Cell Profiling and Bioinformatics Core$426,310
P01 · FY2022 · CA · contact PI
Novel combination therapy for AML expressing mutant RUNX1$534,187
R01 · FY2021 · CA